Please login to the form below

Not currently logged in
Email:
Password:

Richard Vellacott joins Horizon Discovery as chief financial officer

His 15 years’ industry includes time in Deloitte’s life sciences practice

Cambridge, UK-based personalised medicine research tool firm Horizon Discovery has appointed Richard Vellacott as chief financial officer.

He was most recently vice president, finance at hi-tech company CSR, but joins Horizon with over 15 years' experience in working with life science companies.

During this time Vellacott served as a director in Deloitte's life sciences practice, where he specialised in capital market transactions including IPOs, M&A and fundraising on both the UK and the US markets.

Horizon's CEO Dr Darrin Disley said: “I'm delighted to welcome Richard to Horizon. As the company continues to expand, it is essential that we maintain a highly experienced executive team with the skills to deliver our growth objectives. Richard's background is an ideal fit and I very much look forward to working with him.”

8th August 2012

Share


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Watermeadow Medical US

Watermeadow Medical is an award-winning, international agency with offices in Oxford and Manchester, UK and New York, USA. ....

Latest intelligence

England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....
Pharma deal watch - handshake
Pharma deals during March 2014
Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month...